ArticleVirusdisease2023

SARS CoV-2 spike protein variants exploit DC-SIGN/DC-SIGNR receptor for evolution and severity: an in-silico insight.

Jyoti Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.